Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 May;106(1):180–186. doi: 10.1111/j.1476-5381.1992.tb14312.x

Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin-1 [1-38] in conscious rats.

S M Gardiner 1, P A Kemp 1, T Bennett 1
PMCID: PMC1907463  PMID: 1387023

Abstract

1. Regional haemodynamic responses to atrial natriuretic peptide (ANP, 0.5 nmol kg-1) or proendothelin-1 [1-38] (1.0 nmol kg-1) were assessed in the same conscious Long Evans rats before and 20 min after administration of the novel neutral endopeptidase (NEP) inhibitor, SQ 28,603 (50 mg kg-1, i.v.). In a separate experiment, responses to endothelin-1 (0.5 nmol kg-1), angiotensin I (0.25 nmol kg-1) and angiotensin II (0.12 nmol kg-1) were measured before and after administration of SQ 28,603. 2. SQ 28,603 alone had no significant cardiovascular effects but caused significant prolongation of the hypotensive, tachycardic and renal and mesenteric vasoconstrictor effects of ANP. However, the early vasodilator and late vasoconstrictor responses in the hindquarters were not affected significantly. 3. SQ 28,603 caused significant attenuation of the pressor effects of proendothelin-1 [1-38] but the associated bradycardia was unchanged. SQ 28,603 caused a significant inhibition of the renal and mesenteric vasoconstrictor effects of proendothelin-1 and also inhibited the initial vasodilator and subsequent vasoconstrictor responses in the hindquarters vascular bed. 4. SQ 28,603 had no significant effects on the haemodynamic responses to endothelin-1, angiotensin I, or angiotensin II. 5. The results are consistent with SQ 28,603 not only inhibiting NEP that is involved in the degradation of ANP, but also suppressing activity of the enzyme involved in the conversion of proendothelin-1 [1-38] to endothelin-1.

Full text

PDF
180

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen D. E. Effect of sympathectomy on renal and circulatory action of atrial natriuretic peptide. Am J Physiol. 1990 Dec;259(6 Pt 2):R1274–R1280. doi: 10.1152/ajpregu.1990.259.6.R1274. [DOI] [PubMed] [Google Scholar]
  2. Almeida F. A., Suzuki M., Scarborough R. M., Lewicki J. A., Maack T. Clearance function of type C receptors of atrial natriuretic factor in rats. Am J Physiol. 1989 Feb;256(2 Pt 2):R469–R475. doi: 10.1152/ajpregu.1989.256.2.R469. [DOI] [PubMed] [Google Scholar]
  3. Barbee R. W., Harrison-Bernard L. M., Zimmerman R. S., Trippodo N. C., Frohlich E. D. Sympathectomy fails to reveal prominent vasodilation by atrial natriuretic factor. Hypertension. 1990 Jun;15(6 Pt 2):888–893. doi: 10.1161/01.hyp.15.6.888. [DOI] [PubMed] [Google Scholar]
  4. Chiu P. J., Tetzloff G., Romano M. T., Foster C. J., Sybertz E. J. Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats. Am J Physiol. 1991 Jan;260(1 Pt 2):R208–R216. doi: 10.1152/ajpregu.1991.260.1.R208. [DOI] [PubMed] [Google Scholar]
  5. Fozard J. R., Part M. L. No major role for atrial natriuretic peptide in the vasodilator response to endothelin-1 in the spontaneously hypertensive rat. Eur J Pharmacol. 1990 May 3;180(1):153–159. doi: 10.1016/0014-2999(90)90603-4. [DOI] [PubMed] [Google Scholar]
  6. Fukuda Y., Hirata Y., Yoshimi H., Kojima T., Kobayashi Y., Yanagisawa M., Masaki T. Endothelin is a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytes. Biochem Biophys Res Commun. 1988 Aug 30;155(1):167–172. doi: 10.1016/s0006-291x(88)81064-7. [DOI] [PubMed] [Google Scholar]
  7. Fukuroda T., Noguchi K., Tsuchida S., Nishikibe M., Ikemoto F., Okada K., Yano M. Inhibition of biological actions of big endothelin-1 by phosphoramidon. Biochem Biophys Res Commun. 1990 Oct 30;172(2):390–395. doi: 10.1016/0006-291x(90)90685-g. [DOI] [PubMed] [Google Scholar]
  8. Gardiner S. M., Compton A. M., Bennett T., Hartley C. J. Can pulsed Doppler technique measure changes in aortic blood flow in conscious rats? Am J Physiol. 1990 Aug;259(2 Pt 2):H448–H456. doi: 10.1152/ajpheart.1990.259.2.H448. [DOI] [PubMed] [Google Scholar]
  9. Gardiner S. M., Compton A. M., Bennett T. Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats. Br J Pharmacol. 1988 Sep;95(1):197–208. doi: 10.1111/j.1476-5381.1988.tb16565.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gardiner S. M., Compton A. M., Bennett T. Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats. Br J Pharmacol. 1990 Jan;99(1):107–112. doi: 10.1111/j.1476-5381.1990.tb14662.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gardiner S. M., Compton A. M., Bennett T. Regional hemodynamic effects of atrial natriuretic peptide or captopril in Brattleboro rats. Am J Physiol. 1988 Nov;255(5 Pt 2):R737–R743. doi: 10.1152/ajpregu.1988.255.5.R737. [DOI] [PubMed] [Google Scholar]
  12. Gardiner S. M., Compton A. M., Bennett T. Regional hemodynamic effects of calcitonin gene-related peptide. Am J Physiol. 1989 Feb;256(2 Pt 2):R332–R338. doi: 10.1152/ajpregu.1989.256.2.R332. [DOI] [PubMed] [Google Scholar]
  13. Gardiner S. M., Compton A. M., Bennett T. Regional hemodynamic effects of endothelin-1 in conscious, unrestrained, Wistar rats. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S202–S204. doi: 10.1097/00005344-198900135-00057. [DOI] [PubMed] [Google Scholar]
  14. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T. Regional and cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol. 1990 Nov;101(3):625–631. doi: 10.1111/j.1476-5381.1990.tb14131.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T. The effects of phosphoramidon on the regional haemodynamic responses to human proendothelin [1-38] in conscious rats. Br J Pharmacol. 1991 Aug;103(4):2009–2015. doi: 10.1111/j.1476-5381.1991.tb12368.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gerbes A. L., Vollmar A. M. Degradation and clearance of atrial natriuretic factors (ANF). Life Sci. 1990;47(14):1173–1180. doi: 10.1016/0024-3205(90)90208-9. [DOI] [PubMed] [Google Scholar]
  17. Haywood J. R., Shaffer R. A., Fastenow C., Fink G. D., Brody M. J. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol. 1981 Aug;241(2):H273–H278. doi: 10.1152/ajpheart.1981.241.2.H273. [DOI] [PubMed] [Google Scholar]
  18. Hofbauer K. G., Criscione L., Sonnenburg C., Muir A., Mah S. C. Acute and chronic haemodynamic and natriuretic effects of atriopeptin II in conscious rats. J Hypertens Suppl. 1986 Jun;4(2):S41–S47. [PubMed] [Google Scholar]
  19. Lappe R. W., Smits J. F., Todt J. A., Debets J. J., Wendt R. L. Failure of atriopeptin II to cause arterial vasodilation in the conscious rat. Circ Res. 1985 Apr;56(4):606–612. doi: 10.1161/01.res.56.4.606. [DOI] [PubMed] [Google Scholar]
  20. Matsumura Y., Hisaki K., Takaoka M., Morimoto S. Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1. Eur J Pharmacol. 1990 Aug 21;185(1):103–106. doi: 10.1016/0014-2999(90)90216-s. [DOI] [PubMed] [Google Scholar]
  21. McMahon E. G., Palomo M. A., Moore W. M., McDonald J. F., Stern M. K. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):703–707. doi: 10.1073/pnas.88.3.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ohlstein E. H., Vickery L., Sauermelch C., Willette R. N. Vasodilation induced by endothelin: role of EDRF and prostanoids in rat hindquarters. Am J Physiol. 1990 Dec;259(6 Pt 2):H1835–H1841. doi: 10.1152/ajpheart.1990.259.6.H1835. [DOI] [PubMed] [Google Scholar]
  23. Pollock D. M., Opgenorth T. J. Evidence for metalloprotease involvement in the in vivo effects of big endothelin 1. Am J Physiol. 1991 Jul;261(1 Pt 2):R257–R263. doi: 10.1152/ajpregu.1991.261.1.R257. [DOI] [PubMed] [Google Scholar]
  24. Sawamura T., Kasuya Y., Matsushita Y., Suzuki N., Shinmi O., Kishi N., Sugita Y., Yanagisawa M., Goto K., Masaki T. Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cells. Biochem Biophys Res Commun. 1991 Jan 31;174(2):779–784. doi: 10.1016/0006-291x(91)91485-u. [DOI] [PubMed] [Google Scholar]
  25. Seymour A. A., Norman J. A., Asaad M. M., Fennell S. A., Little D. K., Kratunis V. J., Rogers W. L. Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase. J Cardiovasc Pharmacol. 1991 Feb;17(2):296–304. doi: 10.1097/00005344-199102000-00016. [DOI] [PubMed] [Google Scholar]
  26. Seymour A. A., Swerdel J. N., Fennell S. A., Druckman S. P., Neubeck R., Delaney N. G. Potentiation of the depressor responses to atrial natriuretic peptides in conscious SHR by an inhibitor of neutral endopeptidase. J Cardiovasc Pharmacol. 1989 Aug;14(2):194–204. doi: 10.1097/00005344-198908000-00003. [DOI] [PubMed] [Google Scholar]
  27. Shen Y. T., Young M. A., Ohanian J., Graham R. M., Vatner S. F. Atrial natriuretic factor-induced systemic vasoconstriction in conscious dogs, rats, and monkeys. Circ Res. 1990 Mar;66(3):647–661. doi: 10.1161/01.res.66.3.647. [DOI] [PubMed] [Google Scholar]
  28. Skolovsky M., Galron R., Kloog Y., Bdolah A., Indig F. E., Blumberg S., Fleminger G. Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4702–4706. doi: 10.1073/pnas.87.12.4702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sybertz E. J., Jr, Chiu P. J., Watkins R. W., Vemulapalli S. Neutral metalloendopeptidase inhibition: a novel means of circulatory modulation. J Hypertens Suppl. 1990 Dec;8(7):S161–S167. [PubMed] [Google Scholar]
  30. Theodorsson-Norheim E. Friedman and Quade tests: BASIC computer program to perform nonparametric two-way analysis of variance and multiple comparisons on ranks of several related samples. Comput Biol Med. 1987;17(2):85–99. doi: 10.1016/0010-4825(87)90003-5. [DOI] [PubMed] [Google Scholar]
  31. Vijayaraghavan J., Scicli A. G., Carretero O. A., Slaughter C., Moomaw C., Hersh L. B. The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J Biol Chem. 1990 Aug 25;265(24):14150–14155. [PubMed] [Google Scholar]
  32. Winquist R. J., Scott A. L., Vlasuk G. P. Enhanced release of atrial natriuretic factor by endothelin in atria from hypertensive rats. Hypertension. 1989 Jul;14(1):111–114. doi: 10.1161/01.hyp.14.1.111. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES